Mapping genomic loci implicates genes and synaptic biology in schizophrenia

PsychENCODE, Psychosis Endophenotypes International Consortium, The SynGO Consortium, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium

Research output: Contribution to journalArticlepeer-review

895 Scopus citations

Abstract

Schizophrenia has a heritability of 60–80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies.

Original languageEnglish
Pages (from-to)502-508
Number of pages7
JournalNature
Volume604
Issue number7906
DOIs
StatePublished - 21 Apr 2022
Externally publishedYes

Funding

FundersFunder number
EU H2020847776
European Commission Horizon 2020
Fundación Familia Alonso
KG Jebsen Stiftelsen
Key Research Program of Frontier SciencesQYZDJ-SSW-SYS009, XDB38000000
Madrid Regional GovernmentB2017/BMD-3740 AGES-CM-2
Medical Research Council CentreG0800509, MR/L010305/1
NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust
NIHR Biomedical Research Centre for Mental Health
National Scientific Research Program
Psychosis Endophenotypes International Consortium
South-East Norway Health Authority
UK Royal Society-Newton Advanced FellowshipNAF\R1\191094
Wellcome Trust Case Control Consortium
National Institutes of Health
National Institute of Mental HealthU01 MH109536-01, U01MH109514, K01MH121659, 5R01MH101519
National Institute of Mental Health
Fundación Alicia Koplowitz
Takeda Pharmaceutical Company
King’s College London
South London and Maudsley NHS Foundation Trust
National Alliance for Research on Schizophrenia and Depression
Mental Health Research UK
Wellcome Trust085475/Z/08/Z, 085475/B/08/Z
Wellcome Trust
Horizon 2020 Framework Programme667302, 728018
Horizon 2020 Framework Programme
Seventh Framework Programme747429, 115916, 602805, 777394
Seventh Framework Programme
Pennsylvania Game Commission
Medical Research CouncilG1100583, PDA/02/06/016, G0901310
Medical Research Council
Economic and Social Research Council
University College London
European Commission
Cardiff University
National Medical Research CouncilIP6003 –VZFNM00064203, LM2018132, CZ.02.1.01/0.0/0.0/18_046/0015515, NMRC/TCR/003/2008
National Medical Research Council
Fundação de Amparo à Pesquisa do Estado de São Paulo2014/07280-1 2011/50740-5, 2010/08968-6
Fundação de Amparo à Pesquisa do Estado de São Paulo
National Natural Science Foundation of China31771388, 32041008, 31961130380, 91731303, 31525014
National Natural Science Foundation of China
Chinese Academy of Sciences
Science and Technology Commission of Shanghai Municipality2017SHZDZX01
Science and Technology Commission of Shanghai Municipality
Instituto de Salud Carlos IIISAM16PE07CP1, PI16/02012, PI19/024
Instituto de Salud Carlos III
National Health Research InstitutesNIHR200756
National Health Research Institutes
Ministerio de Ciencia e Innovación
Seventh Framework Programme
Norges Forskningsråd223273, 248828, 248980, 283798, 248778, 262656, 273291
Norges Forskningsråd
Centro de Investigación Biomédica en Red de Salud Mental
European Regional Development Fund
Innovative Medicines InitiativeAIMS-2-TRIALS
Innovative Medicines Initiative
Nemzeti Kutatási Fejlesztési és Innovációs HivatalK 138669
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
UCLH Biomedical Research Centre

    Fingerprint

    Dive into the research topics of 'Mapping genomic loci implicates genes and synaptic biology in schizophrenia'. Together they form a unique fingerprint.

    Cite this